|
Optical Coherence Tomography Comparative Study Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Optical Coherence Tomography Comparative Study conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Optical Coherence Tomography Comparative Study Clinical research trials and Optical Coherence Tomography Comparative Study medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Optical Coherence Tomography Comparative Study. Optical Coherence Tomography Comparative Study Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Optical Coherence Tomography Comparative Study clinical trial. Subjects often receive the most expert healthcare possible for their Optical Coherence Tomography Comparative Study condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "O" Clinical Trials Conditions > Optical Coherence Tomography Comparative Study  Optical Coherence Tomography Comparative Study
Optical Coherence Tomography Comparative Study
For Condition: Retinal Disease,Healthy
Status: Recruiting
Sponsor(s): National Eye Institute (NEI) ,
Synopsis: This study, conducted at the NIH Clinical Center and the University of Wisconsin University, will compare measurements obtained using older and newer models of a machine called an optical coherence tomography (OCT) scanner. This instrument uses a beam of light to measure the thickness of the retina, the light-sensitive inner lining of the back of the eye. OCT measurements will be done in multicenter clinical trials of new treatments for disorders that cause vision loss, such as macular edema. Because some centers in these studies will use the older OCT model and some the newer one, it is necessary to determine whether the two models give comparable results. People 18 years of age and older in the following categories may be eligible for this study: - People with diabetes, with or without macular edema; - People with other retinal disease, such as uveitis or vein occlusion in the retina; - People with no history of eye disease who have a normal retina. Participants will have the following tests and procedures: - Eye examination to assess vision and eye pressure and to evaluate the retina. The pupils are dilated with drops for this examination. - Stereoscopic color fundus photography to examine the back of the eye. Eye drops are used to enlarge the size of the pupils to allow for a through examination and photographs of the eye using a special camera that flashes a bright light into the eye. - OCT to measure retinal thickness. For this procedure, the subject sits in front of a small screen and looks at a target in the center of the screen while a dim red light moves across the subject's retina. This test is done first with one model of the OCT scanner, then the other. Finally, the test is repeated in both eyes with whichever model was used first. Patients who are being treated for macular edema will repeat the same tests at their 3-month visits.
Details: The use of the Optical Coherence Tomography (OCT) has increased markedly over the recent years for clinical research. It is a promising new method for imaging the retina, measuring its thickness, and displaying some features of this structure. It is useful in assessing several eye diseases, including macular edema from various causes and abnormalities of the vitreoretinal interface. There is a broad clinical consensus that OCT is superior to stereoscopic color fundus photography, fluorescein angiography, and clinical biomicroscopic examination in measuring retinal thickness and is capable of documenting fairly small changes in thickness. OCT is becoming an important part of clinical trials of new treatments for macular edema. A number of models of OCT have been available commercially, models 1, 2, and 3. A number of models of OCT have been used in clinical centers involved in such clinical research. Comparisons of 2 models 2 and 3 as well as the reproducibility of these measurements have not been conducted. The main research questions to be answered in this protocol are the following, in patients with normal retina, diabetic macular edema, macular edema from other causes, or other vitreoretinal abnormalities: 1. Is the standard deviation of the differences of sequential measurements of retinal thickness in normal retinas using OCT 3 similar to those measured with the OCT 2? 2. Is the standard deviation of the differences of sequential measurements of retinal thickness in patients with diabetes with and without retinopathy, or other causes of macular edema, using the OCT 3 similar to those measured with the OCT 2? 3. Are the systematic differences between thickness measurements using OCT2 and OCT3 in the same eyes? 4. Are there differences in the ability of each machine to image abnormalities within the vitreoretinal interface?
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: 1. Patient must understand and sign the informed consent. 2. Patient must be at least 18 years of age. 3. Pupillary dilation to at least 6 mm must be possible. 4. Ocular media must be sufficiently clear to allow for quality images. EXCLUSION CRITERIA: 1. Any condition such as corneal opacifiation that precludes adequate slit lamp examination and photography of the fundus.
Total Enrollment: 120
Location and Contact Information:
National Eye Institute (NEI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 030294; 03-EI-0294
Study Start Date: September 15, 2003
Record last reviewed: July 7, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00069199
Other Retinal Disease Studies:
1. Dynamics of Leptin and Endocrine Function
2. Studies of Frontal Lobe Brain Functioning in Schizophrenia
3. Investigation into the Use of Ultrasound Technique in the Evaluation of Heart Disease
4. Effect of Alprazolam on Anxiety
5. Bone Loss in Premenopausal Women with Depression
Related Studies:
Other Retinal Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Optical Coherence Tomography Comparative Study
|
|
|
|
|
|
|
|
